Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

Blood

Volumn 100, Issue 4, 2002, Pages 1354-1361

  Scandella, Elke ^a,b   Men, Ying ^a,b   Gillessen, Silke ^a,b   Förster, Reinhold ^a,b   Groettrup, Marcus ^a,b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CYCLIC AMP; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0037103366     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-11-0017     Document Type: Article

References (56)

1. Dendritic cells and the control of immunity
2. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells
3. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
4. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
5. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major hisotcompatibility complex class II compartment: Downregulation by cytokines and bacterial products
6. Inflamatory stimuli induce accumulation of MHC class II complexes on dendritic cells
7. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
8. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
9. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
10. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
11. Chemokines and cell migration in secondary lymphoid organs
12. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells
13. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
14. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymphnodes
15. Dendritic cell migration to lymph nodes: Cytokines, chemokines, and lipid mediators
16. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes
17. Efficient presentation of soluble antigen by cultured human dedritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
18. Signals required for differentiating dendritic cells from human monocytes in vitro
19. Migration of human dendritic cells after injection in patients with metastatic malignancies
20. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
21. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
22. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
23. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
24. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
25. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes
26. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation
27. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
28. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
29. Innate and adaptive immunity to tumors: IL-12 is required for optimal responses
30. The critical role of Th1-dominant immunity in tumor immunology
31. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice
32. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
33. Prostanoid receptors: Subtypes and signaling
34. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation
35. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages
36. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins
37. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
38. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
39. Potential involvement of IL-10 in suppressing tumor-associated macrophages: Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10
40. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7
41. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7
42. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys
43. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells
44. Leukocyte polarization in cell migration and immune interactions
45. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: Involvement of cAMP signaling pathway
46. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms
47. Lipid mediator networks in cell signaling: Update and impact of cytokines
48. Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2
49. The disabled dendritic cell
50. Autoregulation of human monocytederived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production
51. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their tra0fficking properties
52. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: Downregulation of CCR5 expression by cyclic adenosine monophosphate
53. Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1
54. IL-4 is a mediator of IL-12p70 induction by human Th2-cells: Reversal of polarized Th2 phenotype by dendritic cells
55. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1
56. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells